Zentiva and Euractiv Host Key Health Policy Conference in Brussels

Bridging Gaps in Health Policy: Zentiva's Initiative in Brussels

In a significant move towards reshaping the European healthcare landscape, Zentiva took an active role in Euractiv's Health Policy Conference held in Brussels. This event gathered prominent EU policymakers and industry stakeholders to discuss pivotal issues surrounding access to medicines. The CEO of Zentiva, Steffen Saltofte, shared the platform during the pivotal opening panel titled "The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All."

A Call for Unity in Healthcare

At the conference, Saltofte emphasized the need for a collective approach that prioritizes patients' rights in healthcare policy. He underscored the importance of integrating diverse healthcare stakeholders, including pharmaceutical innovators, the off-patent sector, regulators, and policymakers. "Health is a fundamental right," he stated, calling for a unified framework that guarantees sustainable healthcare accessible for everyone.

Building Resilience in Healthcare

A robust healthcare system requires resilience, which Saltofte highlighted in his address. He pointed out that Zentiva's European production sites managed to maintain their supply during the recent COVID-19 pandemic and subsequent shortages. However, he insisted that continued success depends on a systemic framework that assures predictable pricing and cohesive policy alignment focused on patients.

"Investing in our health system is essential," he asserted. Saltofte noted that achieving equitable access to medicines necessitates collaboration among all parties involved, ensuring availability, affordability, and accessibility for every individual who relies on these essential resources.

Key Discussions: Equal Access and Timely Competition

During the panel discussions, Zentiva highlighted several critical issues: the necessity for pharmaceutical reforms that secure early access for patients through fair competition. Extending exclusivity periods was cited as a potential barrier that could delay the introduction of generics and biosimilars — ultimately affecting their affordability and availability for patients.

Saltofte reinforced the notion that resilience is contingent on viable manufacturing within the EU. He called for innovative pricing structures and strategic investments that would boost local production capabilities across a broad range of medicines.

Essential Policy Alignment

Emphasizing the need for harmony across industrial, pharmaceutical, and environmental policies, the Zentiva team outlined that an absence of coordinated action could hinder medication supply and compromise innovation within eco-friendly technologies. Addressing this disconnect is vital for fostering a sustainable healthcare model.

Embracing Modern Solutions

Zentiva advocates for reforms that support the swift integration of digital tools in healthcare, urging for systems that reflect real-world costs. Saltofte mentioned initiatives like digital leaflets and incentive programs for value-added medicines as pathways to achieving this goal.

Collaboration is Key

Moderated by EURACTIV's Anna Gumbau, the panel included key figures such as Rainer Becker from the European Commission, and Members of the European Parliament Stine Bosse and Ondřej Knotek. These discussions are seen as fundamental to fostering collaboration and advancing progress that benefits everyone who relies on medications.

About Zentiva

Zentiva has a long-standing commitment to ensuring health and well-being for generations. Operating in over 30 countries, the company focuses on developing high-quality, affordable medicines. With a robust network of manufacturing partners and facilities, it aims to secure supply sustainability amidst increasing global health demands. The company's roots trace back over 500 years to a pharmacy in Prague, reflecting a deep commitment to future generations. Zentiva aspires to remain a trusted provider of health solutions well into the future.

For more detailed insights and updates, visit Zentiva.